TARGAXAN, an innovative treatment for hepatic encephalopathy.

“TARGAXAN ® ▼ 550 (rifaximin-α 550mg), an innovative treatment for hepatic encephalopathy (HE), will be available to patients in England and Wales following its approval by the National Institute for Health and Care Excellence(NICE). [1] Hepatic encephalopathy is a serious and potentially life-threatening neuropsychiatric condition associated with advanced liver disease that affects around 10,000 patients in the UK. [2] , [3] , [4] Norgine markets this innovative treatment which is licensed for the reduction in recurrence of episodes of overt hepatic encephalopathy in patients of 18 years of...